Updates are available Correction dated 2022-03-07
Click to view Correction: https://doi.org/10.1038/s41467-022-28979-1
-
Authors
Sushentsev, Nikita https://orcid.org/0000-0003-4500-9714
McLean, Mary A.
Warren, Anne Y.
Benjamin, Arnold J. V. https://orcid.org/0000-0003-2063-8258
Brodie, Cara
Frary, Amy https://orcid.org/0000-0002-4373-3517
Gill, Andrew B.
Jones, Julia https://orcid.org/0000-0001-9819-8091
Kaggie, Joshua D. https://orcid.org/0000-0001-6706-3442
Lamb, Benjamin W. https://orcid.org/0000-0003-2220-893X
Locke, Matthew J.
Miller, Jodi L. https://orcid.org/0000-0001-6870-204X
Mills, Ian G.
Priest, Andrew N. https://orcid.org/0000-0002-9771-4290
Robb, Fraser J. L.
Shah, Nimish
Schulte, Rolf F.
Graves, Martin J. https://orcid.org/0000-0003-4327-3052
Gnanapragasam, Vincent J.
Brindle, Kevin M. https://orcid.org/0000-0003-3883-6287
Barrett, Tristan
Gallagher, Ferdia A. https://orcid.org/0000-0003-4784-5230
-
Funding
Funding for this research was provided by:
Gates Cambridge Trust
Prostate Cancer UK
Cancer Research UK
- License Information
-
More Information
Article History
Received: 2 July 2021
Accepted: 2 December 2021
First Online: 24 January 2022
Change Date: 7 March 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-022-28979-1
Competing interests
: The authors declare the following competing interests: F.A.G. has research support from GE Healthcare, grants from GlaxoSmithKline, and has consulted for AstraZeneca on behalf of the University of Cambridge. K.M.B. has research support from GE Healthcare. F.J.L.R. and R.S.S. are GE Healthcare employees. The remaining authors declare no competing interests.
